Petros Pharmaceuticals, Inc. (PTPI) earnings
PTPI earnings moved a median of -4.51% by the close. Quarterly and annual PTPI reports and results, each read against the price at its own news timestamp. Back to the PTPI overview →
12 measured PTPI earnings events.
Where these PTPI earnings landedvs 12 measured PTPI earnings reactions
| Middle 50% of PTPI earnings reactions | -10.32% to -0.48% |
|---|---|
| Median reaction (to close) | -4.51% |
| Measured reactions | 12 |
Point-in-time · zero look-ahead
Half of the 12 PTPI earnings events with a measured close landed between -10.32% and -0.48%; 25% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Petros Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -10.00% | |
| Form 10-Q Petros Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | -11.11% | -5.56% | |
| Form 10-K Petros Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | +0.00% | +13.33% | |
| Form NT 10-K Petros Pharmaceuticals, For: Dec 31 | SEC filing · Form NT | -1.72% | -6.32% | |
| Form 10-Q Petros Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -1.29% | |
| Form 10-Q Petros Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | -9.87% | -11.27% | |
| Form 10-K Petros Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | +2.58% | +35.48% | |
| Form 10-Q Petros Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | +1.21% | -3.46% | |
| Form 10-Q Petros Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -0.65% | |
| Form 10-K/A Petros Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | -0.60% | -20.15% | |
| Form 10-Q Petros Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | +3.98% | +0.02% | |
| Form 10-K Petros Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | -7.45% | -11.57% |
Keep exploring
More PTPI: analyst actions → · SEC filings → · PTPI overview →